This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Institute for Regeneration and Repair
edinuni-irr.bsky.social
did:plc:b6hl7vqmluzqil4dgcgloplw
IRR spinout Resolution Therapeutics doses first patient in clinical trial
The first patient has been dosed and safety cleared in the Phase I/II EMERALD study of its novel therapy for end-stage liver disease.
@edinnovations.bsky.social
Read the article: edin.ac/4ndJdHU
https://edin.ac/4ndJdHU
2025-09-03T11:45:12.406Z